Combination therapy with hibiscus acid improves outcomes in mice infected with multidrug-resistant bacteria, indicating potential for new treatments.
The antibacterial effect of chloramphenicol, hibiscus acid, and a mixture of hibiscus acid and chloramphenicol against antibiotic-resistant enterohemorrhagic Escherichia coli (EHEC) and Salmonella Typhimurium (ST) was determined in Caesarean-Derived (CD)-1 mice. Hibiscus acid was isolated from Hibiscus sabdariffa calyces. The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of chloramphenicol (CH), hibiscus acid (HA), and mixtures of HA/CH were determined for EHEC and ST. 11 groups of six mice each were formed. Four groups were inoculated orally with 4 log10 Colony forming units (CFU) of ST, four groups were inoculated with 4 log10 CFU of EHEC, and the remaining three groups were not inoculated. Six hours post inoculation, the mice in some groups received, via the oral route, solutions of hibiscus acid (7 mg/mL), chloramphenicol (82 µg/mL), a mixture of HA/CH (5.7 mg/mL HA and 4 µg/mL CH), or isotonic saline solution. The MIC and MBC values were between 7 and 5 mg/mL for hibiscus acid, between 17.6 and 82 µg/mL for chloramphenicol, and between 4.2 mg/mL/0.3 µg/mL and 5.7 mg/mL/0.4 µg/mL (concentration of hibiscus acid/concentration of chloramphenicol) or HA/CH. EHEC and ST were not detected in the feces of mice that were administered hibiscus acid alone or in mixture with chloramphenicol. By contrast, pathogens were isolated from the feces of untreated mice and those treated with chloramphenicol alone throughout the study.
No takes yet. Share an insight, caveat, or question.
Portillo-Torres et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: